VA-DATAXSTREAM
23.4.2024 15:08:30 CEST | Business Wire | Press release
DataXstream LLC, an SAP solution provider focused on order management and point of sale for sales and distribution, today announced it is expanding into the Nordic region after a successful implementation of its OMS+ platform across two key business units for the Martin & Servera group, Sweden’s leading restaurant and catering distributor that specializes in the needs of the restaurant industry.
Learn more about DataXstream OMS+ here.
Martin & Servera is a group of companies based in Stockholm who was faced with the challenge of managing multiple ERP systems that were facing end of life, so they decided to consolidate onto a single instance of SAP S/4 HANA for all their business units. As part of this migration, Martin & Servera turned to DataXstream’s OMS+ cross-channel order management platform to help them enable faster order entry and streamline their sales and order processes between all companies within their organization.
Working with DataXstream’s LATAM delivery team, Kötthallen Sorunda, Sweden's leading wholesaler of meat, game, poultry and charcuterie and Fiskhallen Sorunda, the leading sustainable seafood wholesaler in Sweden, were the first two business units to successfully deploy OMS+ across their live networks. The go-live transition went exceptionally smooth, with over 500 orders created on the first day to meet the demand for the next three days.
“The complex nature of Martin & Servera’s sales and order management environment is exactly what OMS+ is built for. They are processing over 15,000 sales order lines a month and can now streamline and automate those processes in a fraction of the time, resulting in faster order entry and a better customer experience. This go-live stands out as one of the best I have ever been part of, thanks to the excellent integration, support and collaboration between Martin & Servera, the systems integrator, DataXstream and the Steering Committee,” said Diego Perelman, President, DataXstream LATAM. “Our move into the Nordic region highlights the continued need among B2B organizations to reduce complexity and streamline sales order processes within SAP SD environments.”
The OMS+ Difference
The ease of deployment across Martin & Servera’s newly installed S/4 HANA backbone is another hallmark of OMS+ as the only platform on the market today that is directly embedded into SAP as a single interface. This allows Martin & Servera to seamlessly align all their companies’ ERPs and applications onto a single platform, reducing complexity and customization, while giving them access to the same real-time master data from SAP and supporting their unique business needs.
As a result, OMS+ will equip Martin & Servera’s sales associates with:
- Real-time visibility into customer history, discounts, and product availability
- Faster manual order entry capabilities
- Access to real-time material characteristics to swiftly find the right materials for customers
- Full sales communications and tracking
Additionally, as OMS+ is embedded into SAP, it aligns perfectly with their roadmap, ensuring that new SAP functionalities are automatically available in OMS+ and the flexibility of its interface will allow Martin & Servera to adjust it easily to their unique requirements.
“We had several challenges associated with this project including an ongoing S/4 implementation that was going on in parallel to the OMS+ deployment,” said Thomas Tolvanen, IT Manager, Grönsakshallen Sorunda AB. “We are incredibly impressed by DataXstream and their professional delivery team. They have been instrumental in the S/4 process design to streamline our processes and complexity. Likewise, their deep knowledge and expertise to identify bugs and errors in customization and master data has been invaluable to us during this process. DataXstream is one of our most valuable partners.”
For additional information, please visit www.dataxstream.com or find us on the SAP store at https://store.sap.com/dcp/en/product/display-0000006561_live_v1
About Martin & Servera
The Martin & Servera group offers goods, services and knowledge for restaurants and commercial kitchens in Sweden. We are a Swedish, family-owned group. Responsible and long-term business is an important part of our business. The Martin & Servera group consists of Martin & Servera Restauranghandel, Martin & Servera Logistics, Martin & Servera Restaurant Shops, Galatea, the Vegetable Hall Sorunda, the Fish Hall Sorunda and the Meat Hall Sorunda.
About DataXstream
DataXstream is an SAP® Gold and Endorsed App Partner dedicated to building solutions on emerging technologies that maximize the ROI of our customers’ SAP® infrastructure. As members of the SAP® marketplace, DataXstream’s products can be found in the SAP® Store. Your company is already running the most powerful ERP solution; empower your employees with DataXstream’s OMS+ to take your organization’s sale and customer buying experience to new levels.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423069303/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom